168 related articles for article (PubMed ID: 12909741)
1. Novel gene therapy approaches to pancreatic cancer.
Katz MH; Bouvet M
Int J Gastrointest Cancer; 2003; 33(1):89-97. PubMed ID: 12909741
[TBL] [Abstract][Full Text] [Related]
2. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.
Pisters PW; Abbruzzese JL; Janjan NA; Cleary KR; Charnsangavej C; Goswitz MS; Rich TA; Raijman I; Wolff RA; Lenzi R; Lee JE; Evans DB
J Clin Oncol; 1998 Dec; 16(12):3843-50. PubMed ID: 9850029
[TBL] [Abstract][Full Text] [Related]
3. Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future.
Goel G; Sun W
J Hematol Oncol; 2015 May; 8():44. PubMed ID: 25935754
[TBL] [Abstract][Full Text] [Related]
4. Current standards and new innovative approaches for treatment of pancreatic cancer.
Conroy T; Bachet JB; Ayav A; Huguet F; Lambert A; Caramella C; Maréchal R; Van Laethem JL; Ducreux M
Eur J Cancer; 2016 Apr; 57():10-22. PubMed ID: 26851397
[TBL] [Abstract][Full Text] [Related]
5. Pancreaticobiliary cancer: the future aspects of medical oncology.
van Riel JM; Giaccone G; Pinedo HM
Ann Oncol; 1999; 10 Suppl 4():296-9. PubMed ID: 10436844
[TBL] [Abstract][Full Text] [Related]
6. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy of pancreatic cancer.
Willett CG; Czito BG; Bendell JC
Cancer J; 2007; 13(3):185-91. PubMed ID: 17620768
[TBL] [Abstract][Full Text] [Related]
8. The future of surgery for pancreatic cancer.
Slavin J; Ghaneh P; Jones L; Sutton R; Hartley M; Neoptolemos JP
Ann Oncol; 1999; 10 Suppl 4():285-90. PubMed ID: 10436842
[TBL] [Abstract][Full Text] [Related]
9. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
Buanes TA
World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
[TBL] [Abstract][Full Text] [Related]
10. Management of borderline resectable pancreatic adenocarcinoma.
Jia Y; Wang TJ; Allendorf J; Saif MW
JOP; 2012 Mar; 13(2):147-50. PubMed ID: 22406587
[TBL] [Abstract][Full Text] [Related]
11. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy for resectable pancreatic adenocarcinoma: review of the current treatment approaches and future directions.
Antoniou G; Kountourakis P; Papadimitriou K; Vassiliou V; Papamichael D
Cancer Treat Rev; 2014 Feb; 40(1):78-85. PubMed ID: 23810287
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic adenocarcinoma: treating a systemic disease with systemic therapy.
Sohal DP; Walsh RM; Ramanathan RK; Khorana AA
J Natl Cancer Inst; 2014 Mar; 106(3):dju011. PubMed ID: 24563516
[TBL] [Abstract][Full Text] [Related]
14. Multimodality management of localized pancreatic cancer.
Wayne JD; Wolff RA; Pisters PW; Evans DB
Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
[TBL] [Abstract][Full Text] [Related]
15. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
[TBL] [Abstract][Full Text] [Related]
16. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
17. [Neoadjuvant therapy in pancreatic cancer].
Ji JF; Li ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):644-7. PubMed ID: 16274051
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study.
Aadam AA; Evans DB; Khan A; Oh Y; Dua K
Gastrointest Endosc; 2012 Jul; 76(1):67-75. PubMed ID: 22483859
[TBL] [Abstract][Full Text] [Related]
19. Effect of different treatment methods on survival in patients with pancreatic cancer.
Brasiūniene B; Juozaityte E; Inciūra A; Brasiūnas V; Barauskas G
Rocz Akad Med Bialymst; 2003; 48():66-9. PubMed ID: 14737944
[TBL] [Abstract][Full Text] [Related]
20. Molecular therapy in pancreatic adenocarcinoma.
MacKenzie MJ
Lancet Oncol; 2004 Sep; 5(9):541-9. PubMed ID: 15337483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
